Immucor Inc. (NSDQ:BLUD) tapped the former CEO of Medtronic Inc. (NYSE:MDT) to be its new CEO, succeeding Joshua Levine as of Oct. 17.
Immucor, which was the target of a $1.97 billion takeover by TPG Capital affiliate IVD Holdings Inc. in July, said Hawkins will also serve as an advisor to TPG "on its ongoing efforts to identify investment opportunities in the healthcare industry," according to a press release. Levine is stepping down for personal reasons, he said.